A WunderSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
[Molecular imaging in rheumatoid arthritis]A Wunder
Center for Molecular Imaging Research Massachusetts, General Hospital Havard Medical School, Charlestown, MA 02129, USA
Z Rheumatol 62:II33-6. 2003..Therefore, the choice of the imaging modality for molecular imaging depends on the questions that need to be answered. This review discusses the potential of imaging modalities for molecular imaging in rheumatoid arthritis (RA)...
[Current state of molecular imaging research]J Grimm
Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
Rofo 177:326-37. 2005..This article comprises a review of current technologies of molecular imaging, describes the development of contrast agents and various imaging modalities, new applications in specific disease models, and potential future developments...
Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivoC Fiehn
Department of Haematology, Oncology and Rheumatology, Clinic of Internal Medicine V, University of Heidelberg, Germany
Ann Rheum Dis 63:884-6. 2004..The effects of MTX and MTX-HSA were not significantly different between these two groups. CONCLUSION: Treatment with MTX or MTX-HSA significantly ameliorates cartilage destruction in the SCID mouse model for human RA...
Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTXC Fiehn
Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany
Rheumatology (Oxford) 43:1097-105. 2004..In addition, albumin appears to be taken up by peripheral blood cells, suggesting that they might be one of the potential target cells of this novel anti-arthritic treatment approach...
Molecular imaging: novel tools in visualizing rheumatoid arthritisA Wunder
Division of Rheumatology and Clinical Immunology, Department of Internal Medicine I, University of Regensburg, Germany
Rheumatology (Oxford) 44:1341-9. 2005..With regard to their applicability in rheumatic diseases, we discuss potential molecular targets, current experimental approaches and the future prospects for molecular imaging in rheumatoid arthritis...
